2 Top Marijuana Stocks to Watch in AugustPosted by On

Marijuana cannabis in pot

Since the beginning of the year, the marijuana sector has underperformed dramatically. The effects of COVID-19, oversupply in Canada, and falling consumer spending are all leading investors to get out of weed stocks en masse, with little regard for long-term outlook.

However, the market has changed dramatically from even just a quarter ago. There are now 1,000 marijuana stores open in Canada, and a federal bill to legalize weed in the U.S. was proposed by Sen. Tina Smith (D-Minn.) on July 31. When an entire sector becomes battered, it often creates opportunities for investors to buy top-performing businesses at a bargain price. Today, let’s take a look at two companies that fit this category.

Scientist on marijuana field satisfied with CBD hemp plants.

Image source: Getty Images.

A cannabis company with a solid track record

The fourth quarter of 2020 will be Aphria‘s (NASDAQ:APHA) fifth consecutive quarter of generating positive adjusted earnings before interest, taxes, depreciation, and amortization (EBITDA). During the last quarter of Aphria’s 2020 fiscal year, the company grew its adjusted EBITDA over 40-fold, from $209,000 Canadian dollars in Q4 2019 to CA$8.6 million. Those are pretty tough numbers for other industry competitors to beat, especially during these uncertain times.

Moreover, the company was able to maintain its 52.9% gross margin in selling cannabis. As for other achievements, Aphria also repurchased CA$127.5 million worth of convertible notes during Q4 2020, while possessing CA$497.2 million in cash and cash equivalents to expand its business growth even further.

This company excels at growth. In fiscal 2020, which ended May 31, the company grew its revenue by a staggering 129% to CA$543.3 million, compared with CA$237.1 million in 2019. At the same time, Aphria’s selling price for its cannabis products increased, while its cash cost decreased. With robust revenue growth, increasing efficiency, and a track record of realizing profits, Aphria is definitely one of the top stocks to buy for the month.

If that isn’t enough, the company is trading at a market cap of just CA$1.8 billion. Consider the largest company in the sector, Canopy Growth (NYSE:CGC), which has a market cap of $6 billion but is still not profitable on an adjusted EBITDA basis.

A resilient weed grower 

While Aphria’s momentum has been nothing short of remarkable, one important thing to note is that the company divested all of its U.S. cannabis assets in September 2018. But fellow Canadian marijuana company Cronos Group (NASDAQ:CRON) has begun operations in the U.S., positioning itself to ride the legalization wave. In the short six…

Original Author Link click here to read complete story..



Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.